Technical Analysis for ACHV - Achieve Life Sciences, Inc.

Grade Last Price % Change Price Change
grade C 3.49 -8.88% -0.34
ACHV closed down 8.88 percent on Friday, May 17, 2019, on 38 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Earnings due: Jun 10

*** please verify all earnings dates ***
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical ACHV trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -8.88%
New Downtrend Bearish -8.88%
Spinning Top Other -8.88%
Bollinger Band Squeeze Range Contraction -8.88%
Earnings Movers Other -8.88%

Older signals for ACHV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Biopharmaceutical Cancer Cancers Prostate Cancer Breast Cancer Non Small Cell Lung Cancer Oncolytics Biotech
Is ACHV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 16 Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call Transcript
May 15 Data readout on Achieve's cytisinicline expected next month; shares down 3% after hours
May 15 Achieve Life Sciences misses by $0.25
May 15 Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update
May 15 The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi
May 7 Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019
Apr 26 ACHV: Final Enrollee, Final Visit
Apr 24 50 Stocks Moving In Wednesday's Mid-Day Session
Apr 24 Midatech Pharma leads healthcare gainers; TrovaGene and Cleveland BioLabs among losers
Apr 24 Achieve Life Sciences up 9% premarket as cytisinicline study nears finish line
See more ACHV news...
Indicators
Indicator Value
52 Week High 14.31
52 Week Low 1.045
Average Volume 590,211
200-Day Moving Average 2.5013
50-Day Moving Average 3.5554
20-Day Moving Average 4.1375
10-Day Moving Average 4.056
Average True Range 0.3109
ADX 37.45
+DI 19.915
-DI 26.3151
Chandelier Exit (Long, 3 ATRs ) 3.6973
Chandelier Exit (Short, 3 ATRs ) 4.4027
Upper Bollinger Band 4.5893
Lower Bollinger Band 3.6857
Percent B (%b) -0.22
BandWidth 21.839275
MACD Line 0.086
MACD Signal Line 0.1979
MACD Histogram -0.1119
Fundamentals Value
Market Cap 38.2 Million
Num Shares 10.9 Million
EPS -56.38
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.03
Resistance 3 (R3) 4.08 3.96 3.94
Resistance 2 (R2) 3.96 3.82 3.93 3.91
Resistance 1 (R1) 3.72 3.73 3.66 3.67 3.88
Pivot Point 3.60 3.60 3.57 3.57 3.60
Support 1 (S1) 3.36 3.46 3.30 3.31 3.10
Support 2 (S2) 3.24 3.37 3.21 3.07
Support 3 (S3) 3.00 3.24 3.04
Support 4 (S4) 2.95